27583127|t|Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway
27583127|a|Aside from its importance in reproduction, estrogen (E2) is known to regulate the proliferation and differentiation of hematopoietic stem cells in rodents. However, the regulatory role of E2 in human hematopoietic system has not been investigated. The purpose of this study is to investigate the effect of E2 on hematopoietic differentiation using human pluripotent stem cells (hPSCs). E2 improved hematopoietic differentiation of hPSCs via estrogen receptor alpha (ER-α)-dependent pathway. During hematopoietic differentiation of hPSCs, ER-α is persistently maintained and hematopoietic phenotypes (CD34 and CD45) were exclusively detected in ER-α positive cells. Interestingly, continuous E2 signaling is required to promote hematopoietic output from hPSCs. Supplementation of E2 or an ER-α selective agonist significantly increased the number of hemangioblasts and hematopoietic progenitors, and subsequent erythropoiesis, whereas ER-β selective agonist did not. Furthermore, ICI 182,780 (ER antagonist) completely abrogated the E2 -induced hematopoietic augmentation. Not only from hPSCs but also from human umbilical cord bloods, does E2 signaling potentiate hematopoietic development, suggesting universal function of E2 on hematopoiesis. Our study identifies E2 as positive regulator of human hematopoiesis and suggests that endocrine factors such as E2 influence the behavior of hematopoietic stem cells in various physiological conditions.
27583127	0	8	Improved	T033	C0184511
27583127	9	38	hematopoietic differentiation	T043	C2262995
27583127	42	47	human	T016	C0086418
27583127	48	70	pluripotent stem cells	T025	C0872076
27583127	75	110	estrogen receptor signaling pathway	T044	C1155500
27583127	140	152	reproduction	T040	C0035150
27583127	154	162	estrogen	T109,T121,T125	C0014939
27583127	164	166	E2	T109,T121,T125	C0014939
27583127	180	188	regulate	T077	C1704735
27583127	193	206	proliferation	T169	C1514485
27583127	211	254	differentiation of hematopoietic stem cells	T043	C2262995
27583127	258	265	rodents	T015	C0035804
27583127	280	295	regulatory role	T077	C1704735
27583127	299	301	E2	T109,T121,T125	C0014939
27583127	305	310	human	T016	C0086418
27583127	311	331	hematopoietic system	T022	C0018957
27583127	345	357	investigated	T169	C1292732
27583127	363	384	purpose of this study	UnknownType	C0681832
27583127	391	402	investigate	T169	C1292732
27583127	407	416	effect of	T080	C1704420
27583127	417	419	E2	T109,T121,T125	C0014939
27583127	423	452	hematopoietic differentiation	T043	C2262995
27583127	459	487	human pluripotent stem cells	T025	C0872076
27583127	489	494	hPSCs	T025	C0872076
27583127	497	499	E2	T109,T121,T125	C0014939
27583127	500	508	improved	T033	C0184511
27583127	509	538	hematopoietic differentiation	T043	C2262995
27583127	542	547	hPSCs	T025	C0872076
27583127	552	575	estrogen receptor alpha	T116,T192	C0665341
27583127	552	600	estrogen receptor alpha (ER-α)-dependent pathway	T044	C1155500
27583127	577	581	ER-α	T116,T192	C0665341
27583127	609	638	hematopoietic differentiation	T043	C2262995
27583127	642	647	hPSCs	T025	C0872076
27583127	649	653	ER-α	T116,T192	C0665341
27583127	670	680	maintained	T169	C1314677
27583127	685	698	hematopoietic	T169	C0229601
27583127	699	709	phenotypes	T032	C0031437
27583127	711	715	CD34	T116,T129	C0054953
27583127	720	724	CD45	T116,T126,T129	C0054961
27583127	743	751	detected	T033	C0442726
27583127	755	774	ER-α positive cells	T025	C0007634
27583127	791	801	continuous	T078	C0549178
27583127	802	804	E2	T109,T121,T125	C0014939
27583127	805	814	signaling	T044	C0037080
27583127	838	858	hematopoietic output	T169	C0229601
27583127	864	869	hPSCs	T025	C0872076
27583127	871	886	Supplementation	T061	C0087111
27583127	890	892	E2	T109,T121,T125	C0014939
27583127	899	921	ER-α selective agonist	T121	C2987634
27583127	922	945	significantly increased	T033	C0243095
27583127	960	974	hemangioblasts	T025	C2350248
27583127	979	1004	hematopoietic progenitors	T025	C2350248
27583127	1021	1035	erythropoiesis	T042	C0014819
27583127	1045	1049	ER-β	T116,T192	C0529099
27583127	1045	1067	ER-β selective agonist	T121	C2987634
27583127	1090	1101	ICI 182,780	T109,T121	C1123005
27583127	1103	1116	ER antagonist	T121	C2267020
27583127	1118	1138	completely abrogated	T033	C0243095
27583127	1143	1145	E2	T109,T121,T125	C0014939
27583127	1155	1168	hematopoietic	T169	C0229601
27583127	1169	1181	augmentation	T061	C1293122
27583127	1197	1202	hPSCs	T025	C0872076
27583127	1217	1222	human	T016	C0086418
27583127	1223	1244	umbilical cord bloods	T031	C0162371
27583127	1251	1253	E2	T109,T121,T125	C0014939
27583127	1254	1263	signaling	T044	C0037080
27583127	1275	1300	hematopoietic development	T042	C2610238
27583127	1313	1331	universal function	T169	C0205245
27583127	1335	1337	E2	T109,T121,T125	C0014939
27583127	1341	1354	hematopoiesis	T042	C0018951
27583127	1377	1379	E2	T109,T121,T125	C0014939
27583127	1383	1401	positive regulator	T077	C1704735
27583127	1405	1410	human	T016	C0086418
27583127	1411	1424	hematopoiesis	T042	C0018951
27583127	1443	1460	endocrine factors	T169	C0521425
27583127	1469	1471	E2	T109,T121,T125	C0014939
27583127	1472	1481	influence	T077	C4054723
27583127	1498	1522	hematopoietic stem cells	T025	C0018956
27583127	1534	1558	physiological conditions	T039	C0031843